Intrinsiqq
Atossa Therapeutics Inc logo

Atossa Therapeutics Inc Insider Trading

ATOS

Compare
Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in May 2025.

Net open-market
$0
0 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
0 / 0
executives and directors
Last open-market buy
May 2025
May 21, 2025

Get an email when ATOS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • May 21, 2025
    Steven C Quay
    President & CEO · bought 11,239 at $0.88
    10K
    45% of stake
  • Mar 26, 2025
    H. Lawrence Remmel
    Director · bought 10,000 at $0.70
    7K
    3891% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ATOS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ATOS

CompareIntrinsic value
RGPXRegenerex Pharma, Inc.
No recent price15
TLPHTalphera Inc.
$0.79+6.76%10
TCRTAlaunos Therapeutics Inc.
$1.66+4.40%10
ASBPAspire Biopharma Holdings Inc.
$7.13-6.80%20
GNLXGenelux Corp.
$2.17-4.82%10
GCANThe Greater Cannabis Company, Inc.
$0.75-24.09%20
ADTXAditxt Inc.
$0.00+33.33%20
LYELLyell Immunopharma, Inc.
$13.80+1.62%10

Spot a number that looks wrong? Check it in ATOS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ATOS

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.